Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-7113b injection phase II/III study in patients with cancer pain (subcutaneous injection)
jRCT2080222685Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of hydromorphone in cancer pain, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080222685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222685.